ArticleFrontiers in immunology2025

HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy.

Valeria Spadotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.